针刺降压用于卒中二级预防:多中心随机对照试验研究方案
本方案为一项大规模、多中心、受试者、评估者与分析者盲的实用性随机对照试验,计划纳入480例高血压合并缺血性卒中患者,随机分为活血散风针刺联合一种降压药加常规卒中治疗组与仅一种降压药加基础治疗组。针刺前6周每周6次、后6周每周3次,随访9个月,主要结局为卒中复发,次要结局包括24小时动态血压、中医证候评分、SF-36、NIHSS、Barthel指数及多项超声检查,同时评估针刺安全性。
要点
- 活血散风针刺联合一种降压药加常规卒中治疗,对照为一种降压药加基础治疗。
- 针刺前6周每周6次、后6周每周3次,随访9个月。
- 主要结局为卒中复发,次要结局含24小时动态血压及多项量表与超声。
核心结论
- 研究旨在确定针刺附加治疗控制血压对卒中二级预防的临床效果。
研究设计与样本
- 大规模、多中心、受试者、评估者与分析者盲的实用性随机对照试验。
- 计划纳入480例高血压合并缺血性卒中患者,随机分为实验组和对照组。
主要发现
- 实验组接受活血散风针刺联合一种降压药加常规缺血性卒中治疗。
- 对照组仅接受一种降压药和缺血性卒中基础治疗。
- 降压药物根据血压水平调整。
关键数值与推荐
- 针刺前6周每周6次,后6周每周3次,其后随访9个月。
- 主要结局为卒中复发。
- 次要结局包括24小时动态血压、中医证候评分、SF-36、NIHSS和Barthel指数,在基线、治疗开始后6周和12周评估。
- 心脏超声、颈动脉超声、经颅多普勒和下肢超声在基线和治疗后12周评估。
- 同时评估针刺的安全性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stroke is the prime cause of morbidity and mortality in the general population, and hypertension will increase the recurrence and mortality of stroke. We report a protocol of a pragmatic randomized controlled trial (RCT) using blood pressure (BP)-lowering acupuncture add-on treatment to treat patients with hypertension and stroke. METHODS: This is a large-scale, multicenter, subject-, assessor- and analyst-blinded, pragmatic RCT. A total of 480 patients with hypertension and ischemic stroke will be randomly assigned to two groups: an experimental group and a control group. The experimental group will receive "HuoXueSanFeng" acupuncture combined with one antihypertensive medication in addition to routine ischemic stroke treatment. The control group will only receive one antihypertensive medication and basic treatments for ischemic stroke. HuoXueSanFeng acupuncture will be given for six sessions weekly for the first 6 weeks and three times weekly for the next 6 weeks. A 9-month follow-up will, thereafter, be conducted. Antihypertensive medication will be adjusted based on BP levels. The primary outcome will be the recurrence of stroke. The secondary outcomes including 24-h ambulatory BP, the TCM syndrome score, the Short Form 36-item Health Survey (SF-36), the National Institute of Health Stroke Scale (NIHSS), as well as the Barthel Index (BI) scale will be assessed at baseline, 6 weeks and 12 weeks post initiating treatments; cardiac ultrasound, carotid artery ultrasound, transcranial Doppler, and lower extremity ultrasound will be evaluated at baseline and 12 weeks after treatment. The safety of acupuncture will also be assessed. DISCUSSION: We aim to determine the clinical effects of controlling BP for secondary prevention of stroke with acupuncture add-on treatment. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02967484 . Registered on 13 February 2017; last updated on 27 June 2017.
引用
- Du YZ, Gao XX, Wang CT, et al. Acupuncture lowering blood pressure for secondary prevention of stroke: a study protocol for a multicenter randomized controlled trial. Trials. 2017. PMID: 28915826. doi:10.1186/s13063-017-2171-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。